Basics of continuous renal replacement therapy in pediatrics

다국어 초록 (Multilingual Abstract)

In the last three decades, significant advances have been made in the care of children requiring renal replacement therapy (RRT). The move from the use of only hemodialysis and peritoneal dialysis to continuous venovenous hemofiltration with or without dialysis (continuous renal replacement therapy, CRRT) has become a mainstay in many intensive care units. The move to CRRT is the result of greater clinical experience as well as advances in equipment, solutions, vascular access, and anticoagulation. CRRT is the mainstay of dialysis in pediatric intensive care unit (PICU) for critically ill children who often have hemodynamic compromise. The advantages of this modality include the ability to promote both solute and fluid clearance in a slow continuous manner. Though data exist suggesting that approximately 25% of children in any PICU may have some degree of renal insufficiency, the true need for RRT is approximately 4% of PICU admissions. This article will review the history as well as the progress being made in the provision of this care in children.

참고문헌 (Reference)

1 Hackbarth RM, "Zero balance ultrafiltration(Z-BUF)in blood-primed CRRT circuits achieves electrolyte and acid-base homeostasis prior to patient connection" 20 : 1328-1333, 2005

2 Ronco C, "Treatment of acute renal failure in newborns by continuous arteriovenous hemofiltration" 29 : 908-915, 1986

3 Hackbarth R, "The effect of vascular access location and size on circuit survival in pediatric continuous renal replacement therapy : a report from the PPCRRT registry" 30 : 1116-1121, 2007

4 McBryde KD, "Renal replacement therapy in the treatment of confirmed or suspected inborn errors of metabolism" 148 : 770-778, 2006

5 Mehta RL, "Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients" 38 : 976-981, 1990

6 Deep A, "Prostacyclin as an anticoagulant for continuous renal replacement therapy in children" 43 : 279-289, 2017

7 Bunchman TE, "Prevention of dialysis disequilibrium by use of CVVH" 30 : 441-444, 2007

8 Bunchman TE, "Phenylacetate and benzoate clearance in a hyperammonemic infant on sequential hemodialysis and hemofiltration" 22 : 1062-1065, 2007

9 Bunchman TE, "Pediatric hemofiltration : normocarb dialysate solution with citrate anticoagulation" 17 : 150-154, 2002

10 Smoyer WE, "Pediatric critical care" Mosby 1998

11 Bunchman TE, "Pediatric convective hemofiltration : normocarb replacement fluid and citrate anticoagulation" 42 : 1248-1252, 2003

12 Brophy PD, "Multi-centre evaluation of anticoagulation in patients receiving continuous renal replacement therapy(CRRT)" 20 : 1416-1421, 2005

13 Bunchman TE, "Management of toxic ingestions with the use of renal replacement therapy" 26 : 535-541, 2011

14 Meyer RJ, "Hemodialysis followed by continuous hemofiltration for treatment of lithium intoxication in children" 37 : 1044-1047, 2001

15 Ronco C, "Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure : a prospective randomised trial" 356 : 26-30, 2000

16 Bunchman TE, "Continuous venovenous hemodiafiltration in infants and children" 25 : 17-21, 1995

17 Bunchman TE, "Continuous arterialvenous diahemofiltration and continuous veno-venous diahemofiltration in infants and children" 8 : 96-102, 1994

18 Garzotto F, "Choice of catheter size for infants in continuous renal replacement therapy : bigger is not always better" 20 : e170-e179, 2019

19 Maxvold NJ, "Amino acid loss and nitrogen balance in critically ill children with acute renal failure : a prospective comparison between classic hemofiltration and hemofiltration with dialysis" 28 : 1161-1165, 2000

20 Clark WR, "Advances in machine technology" 194 : 80-89, 2018

21 Barletta GM, "Acute renal failure in children and infants" 10 : 499-504, 2004

22 Brophy PD, "AN-69 membrane reactions are pH-dependent and preventable" 38 : 173-178, 2001